AstraZeneca to acquire cell therapy company Neogene Therapeutics
AstraZeneca will acquire Neogene Therapeutics, a US-based clinical-stage biotechnology company, for a total consideration of up to $320 million, bringing next-generation transformative cell therapies for cancer treatment. The value of the transaction constitutes an initial payment of $200 million on post-closing and an additional payment of up to $120 million on hitting a certain number […]